The opioid overdose epidemic: opportunities for pharmacists.
作者信息
Wu Li-Tzy, Ghitza Udi E, Burns Anne L, Mannelli Paolo
机构信息
Department of Psychiatry and Behavioral Sciences.
Department of Medicine.
出版信息
Subst Abuse Rehabil. 2017 Jul 31;8:53-55. doi: 10.2147/SAR.S144268. eCollection 2017.
Abstract
摘要
相似文献
1
The opioid overdose epidemic: opportunities for pharmacists.阿片类药物过量流行：药剂师面临的机遇。
Subst Abuse Rehabil. 2017 Jul 31;8:53-55. doi: 10.2147/SAR.S144268. eCollection 2017.
2
How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.药剂师准备好提供非处方纳洛酮了吗？以前的教育和新的培训机会的作用。
Res Social Adm Pharm. 2019 Aug;15(8):1014-1020. doi: 10.1016/j.sapharm.2019.03.003. Epub 2019 Mar 22.
3
Changes in Pharmacists' Perceptions After a Training in Opioid Misuse and Accidental Overdose Prevention.接受阿片类药物滥用及意外过量用药预防培训后药剂师认知的变化
J Contin Educ Health Prof. 2019 Winter;39(1):7-12. doi: 10.1097/CEH.0000000000000233.
4
Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.通过基于药房的纳洛酮处方计划预防阿片类药物过量：医疗服务提供方面的创新。
Subst Abus. 2017 Jan-Mar;38(1):55-60. doi: 10.1080/08897077.2016.1184739. Epub 2016 May 10.
5
Evaluation and optimization of take-home naloxone in an academic medical center.学术医疗中心纳洛酮带回家计划的评估与优化
Ment Health Clin. 2019 Mar 1;9(2):105-109. doi: 10.9740/mhc.2019.03.105. eCollection 2019 Mar.
6
Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.美国印第安卫生服务部的药剂师参与了阿片类药物安全倡议，并扩大了纳洛酮的可及性。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S135-S140. doi: 10.1016/j.japh.2017.01.005.
7
Preparing student pharmacists to identify opioid misuse, prevent overdose and prescribe naloxone.培养学生药剂师识别阿片类药物滥用、预防过量用药并开具纳洛酮处方的能力。
Curr Pharm Teach Learn. 2019 May;11(5):522-527. doi: 10.1016/j.cptl.2019.02.013. Epub 2019 May 3.
8
Naloxone for Opioid Overdose and the Role of the Pharmacist.用于阿片类药物过量的纳洛酮及药剂师的作用
Consult Pharm. 2018 Feb 1;33(2):98-104. doi: 10.4140/TCP.n.2018.98.
9
Why aren't Australian pharmacists supplying naloxone? Findings from a qualitative study.为什么澳大利亚药剂师不供应纳洛酮？一项定性研究的结果。
Int J Drug Policy. 2019 Jul;69:46-52. doi: 10.1016/j.drugpo.2019.03.020. Epub 2019 May 9.
10
Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.评估药剂师准备分发纳洛酮和就应对阿片类药物过量提供咨询的能力。
J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):550-554.e2. doi: 10.1016/j.japh.2019.04.012. Epub 2019 May 17.
引用本文的文献
1
Identifying Prescription-Opioid-Related Risks Using Prescription Drug Monitoring Programs' Algorithms and Clinical Screening Tools.使用处方药监测程序算法和临床筛查工具识别与处方阿片类药物相关的风险。
Pharmacy (Basel). 2023 Oct 13;11(5):164. doi: 10.3390/pharmacy11050164.
2
Feasibility and Acceptability of an Overdose Prevention Intervention Delivered by Community Pharmacists for Patients Prescribed Opioids for Chronic Non-Cancer Pain.社区药剂师为慢性非癌性疼痛开具阿片类药物的患者提供过量用药预防干预措施的可行性和可接受性。
Pharmacy (Basel). 2023 May 22;11(3):88. doi: 10.3390/pharmacy11030088.
3
Comprehensive Medication Management Services with a Holistic Point of View, a Scoping Review.从整体角度看综合药物管理服务：一项范围综述
Pharmacy (Basel). 2023 Feb 16;11(1):37. doi: 10.3390/pharmacy11010037.
4
Quantifying prescribed high dose opioids in the community and risk of overdose.量化社区中开具的高剂量阿片类药物及过量用药风险。
BMC Public Health. 2021 Jun 24;21(1):1174. doi: 10.1186/s12889-021-11162-4.
5
"It's way more than just writing a prescription": A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder.“这不仅仅是开个处方那么简单”：一项关于阿片类药物使用障碍患者对整合与非整合治疗模式偏好的定性研究。
Addict Sci Clin Pract. 2021 Jan 27;16(1):8. doi: 10.1186/s13722-021-00213-1.
6
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.美沙酮-药师合作在阿片类药物使用障碍患者管理中的作用：来自国家药物滥用治疗临床试验网络的多地点研究结果。
Addiction. 2021 Jul;116(7):1805-1816. doi: 10.1111/add.15353. Epub 2021 Jan 11.
7
The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.阿片类药物过量减少关怀连续体方法（ORCCA）：HEALing 社区研究中的循证实践。
Drug Alcohol Depend. 2020 Dec 1;217:108325. doi: 10.1016/j.drugalcdep.2020.108325. Epub 2020 Oct 4.
8
Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population.药师提供的直接面向医疗服务提供者的干预措施以减少医疗保险人群中阿片类药物和苯二氮䓬类药物联合处方的初步调查。
Pharmacy (Basel). 2020 Feb 21;8(1):25. doi: 10.3390/pharmacy8010025.
9
Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.药剂师对纳洛酮和阿片类药物使用障碍药物配药的态度：文献综述范围
Subst Abus. 2019;40(4):476-483. doi: 10.1080/08897077.2019.1616349. Epub 2019 Aug 16.
10
Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review.用于检测阿片类药物使用问题及在社区药房实践中潜在应用的筛查工具：一项综述
Integr Pharm Res Pract. 2019 Jul 19;8:85-96. doi: 10.2147/IPRP.S185663. eCollection 2019.
本文引用的文献
1
Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.药物和阿片类药物滥用相关过量死亡人数增加 - 美国，2010-2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. doi: 10.15585/mmwr.mm655051e1.
2
Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.通过基于药房的纳洛酮处方计划预防阿片类药物过量：医疗服务提供方面的创新。
Subst Abus. 2017 Jan-Mar;38(1):55-60. doi: 10.1080/08897077.2016.1184739. Epub 2016 May 10.
3
Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.引导患者提高阿片类药物安全性：基于社区药房的纳洛酮模式。
Harm Reduct J. 2015 Aug 6;12:25. doi: 10.1186/s12954-015-0058-x.
4
Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.在药学实践中整合处方药监测计划（PDMP）：改善临床决策并支持药剂师的专业判断。
Res Social Adm Pharm. 2016 Mar-Apr;12(2):257-66. doi: 10.1016/j.sapharm.2015.05.008. Epub 2015 Jun 6.
5
Drug-poisoning deaths involving heroin: United States, 2000-2013.2000 - 2013年美国涉及海洛因的药物中毒死亡情况。
NCHS Data Brief. 2015 Mar(190):1-8.
6
Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.最佳实践：通过全面药物治疗管理改善 ACO 中的患者预后和成本。
J Manag Care Spec Pharm. 2014 Dec;20(12):1152-8.
7
Factors associated with provision of addiction treatment information by community pharmacists.社区药剂师提供成瘾治疗信息的相关因素。
J Subst Abuse Treat. 2015 May;52:67-72. doi: 10.1016/j.jsat.2014.11.006. Epub 2014 Nov 21.
8
Medication-assisted therapies--tackling the opioid-overdose epidemic.药物辅助治疗——应对阿片类药物过量流行问题
N Engl J Med. 2014 May 29;370(22):2063-6. doi: 10.1056/NEJMp1402780. Epub 2014 Apr 23.
9
Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008-2011.2008 - 2011年美国按过去一年非医疗用途频率划分的处方阿片类镇痛药来源
JAMA Intern Med. 2014 May;174(5):802-3. doi: 10.1001/jamainternmed.2013.12809.
10
ASHP Statement on the pharmacist's role in substance abuse prevention, education, and assistance.美国药学会关于药剂师在药物滥用预防、教育和援助中的作用的声明。
Am J Health Syst Pharm. 2014 Feb 1;71(3):243-6. doi: 10.2146/sp140002.
Zotero 插件